Thanks for posting that Richie.I like their valuation on kingaroy alone, fair value of .132 c to .266 c .All looks good for a bright future imo.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%